首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1467874

2024-2032 年按產品、產業、應用、最終用戶和地區分類的血漿分餾市場報告

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球血漿分離市場規模達到251億美元。

血漿分餾是指將捐贈的血漿下游加工成挽救生命的療法和藥品。它使用機械分離方法（例如離心、深度過濾、沉澱和色譜法）將血漿分解成單獨的蛋白質或血漿組分。如今，一些現代分餾過程使用酒精濃度、時間、溫度和 pH 值來提取特定的治療性蛋白質。此外，多年來技術複雜性的增加以及過程中病毒減少治療的引入導致了新的蛋白質療法的開發以及產品純度和品質的提高。

血漿分餾市場趨勢：

從人類血漿中分離的蛋白質產品是一類重要的治療藥物，廣泛用於預防、管理和治療危及生命的疾病，例如感染、先天性缺陷、罕見血液疾病、免疫疾病和自體免疫疾病。全球很大一部分人口中這些疾病的盛行率顯著上升，這是推動市場成長的關鍵因素之一。此外，由於許多國家的管理機構對生物製品的品質保證實施了嚴格的法規和標準控制和設置，製造商正在開發具有額外安全功能的血漿分級分離。除此之外，市場參與者正在資助研發 (R&D) 活動，以推動血漿生產技術的進步，以提高產品功效並提高免疫球蛋白 G (IgG) 的回收率，以分離新的血漿蛋白。此外，他們也致力於開發經濟實惠的病毒去活化和加工技術，以安全地利用當地血漿資源。再加上提高產量、維持製程經濟性和管理日益嚴格的監管要求的需求不斷增加，預計將在未來幾年提供有利的市場前景。

本報告回答的關鍵問題

2023 年全球血漿分離市場規模有多大？
2024-2032年全球血漿分離市場的預期成長率是多少？
COVID-19 對全球血漿分離市場有何影響？
推動全球血漿分離市場的關鍵因素是什麼？
基於該產品的全球血漿分離市場的詳細情形如何？
全球血漿分離市場依產業分類是怎樣的？
基於應用的全球血漿分離市場的細分如何？
基於最終用戶的全球血漿分離市場的詳細情形如何？
全球血漿分離市場的關鍵區域有哪些？
全球血漿分離市場的主要參與者/公司有哪些？

市場結構
關鍵參與者
關鍵參與者簡介
- ADMA Biologics
- Bio Products Laboratory Ltd.
- Boccard
- Grifols, SA
- Hemarus Therapeutics Limited
- Intas Pharmaceuticals Limited
- LFB SA
- Merck Group
- Octapharma AG
- PlasmaGen BioSciences Pvt. Ltd.
- SK Plasma Co. Ltd.
- Virchow Biotech Private Limited

簡介目錄圖表

Product Code: SR112024A5973

The global plasma fractionation market size reached US$ 25.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.

Plasma fractionation refers to the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma into individual proteins or plasma fractions using mechanical separation methods, such as centrifugation, depth filtration, precipitation, and chromatography. Nowadays, several modern fractionation processes use alcohol concentrations, time, temperature, and pH to extract specific therapeutic proteins. Moreover, increasing technology complexity over the years and the introduction of in-process viral reduction treatments have resulted in the development of new protein therapeutics and improvement in product purity and quality.

Plasma Fractionation Market Trends:

Protein products fractionated from human plasma are an essential class of therapeutics widely used to prevent, manage, and treat life-threatening conditions, such as infections, congenital deficiencies, rare blood disorders, immunologic disorders, and autoimmune disorders. A significant rise in the prevalence of these conditions among a significant part of the population globally represents one of the key factors impelling the market growth. In addition, manufacturers are developing plasma fractionation with additional safety features due to the implementation of stringent regulations and standard controls and settings by governing agencies of numerous countries on quality assurance of biological products. Apart from this, market players are financing research and development (R&D) activities to launch advancement in plasma production technology to improve product efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins. Furthermore, they are focusing on developing affordable viral inactivation and processing technologies that allow utilization of local plasma resources safely. This, in confluence with the escalating need to improve yield, maintain process economics, and manage increasing regulatory requirements, is anticipated to provide a favorable market outlook in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global plasma fractionation market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, sector, application and end user.

Breakup by Product:

Immunoglobulins

Albumin

Coagulation factor VIII

Coagulation factor IX

Breakup by Sector:

Private Sector

Public Sector

Breakup by Application:

Neurology

Immunology

Hematology

Other Applications

Breakup by End User:

Hospitals and Clinics

Clinical Research Laboratories

Academic Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.

Key Questions Answered in This Report

1. What was the size of the global plasma fractionation market in 2023?
2. What is the expected growth rate of the global plasma fractionation market during 2024-2032?
3. What has been the impact of COVID-19 on the global plasma fractionation market?
4. What are the key factors driving the global plasma fractionation market?
5. What is the breakup of the global plasma fractionation market based on the product?
6. What is the breakup of the global plasma fractionation market based on the sector?
7. What is the breakup of the global plasma fractionation market based on the application?
8. What is the breakup of the global plasma fractionation market based on the end user?
9. What are the key regions in the global plasma fractionation market?
10. Who are the key players/companies in the global plasma fractionation market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Plasma Fractionation Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Immunoglobulins
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Albumin
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Coagulation factor VIII
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Coagulation factor IX
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Sector

7.1 Private Sector
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Public Sector
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Application

8.1 Neurology
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Immunology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Hematology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Other Applications
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Clinical Research Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Academic Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 ADMA Biologics
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
- 15.3.2 Bio Products Laboratory Ltd.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Boccard
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Grifols, S.A.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Hemarus Therapeutics Limited
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Intas Pharmaceuticals Limited
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 LFB S.A.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Merck Group
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Octapharma AG
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 SWOT Analysis
- 15.3.10 PlasmaGen BioSciences Pvt. Ltd.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 SK Plasma Co. Ltd.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
- 15.3.12 Virchow Biotech Private Limited
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Plasma Fractionation Market: Major Drivers and Challenges
Figure 2: Global: Plasma Fractionation Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Plasma Fractionation Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Plasma Fractionation Market: Breakup by Product (in %), 2023
Figure 5: Global: Plasma Fractionation Market: Breakup by Sector (in %), 2023
Figure 6: Global: Plasma Fractionation Market: Breakup by Application (in %), 2023
Figure 7: Global: Plasma Fractionation Market: Breakup by End User (in %), 2023
Figure 8: Global: Plasma Fractionation Market: Breakup by Region (in %), 2023
Figure 9: Global: Plasma Fractionation (Immunoglobulins) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Plasma Fractionation (Immunoglobulins) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Plasma Fractionation (Albumin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Plasma Fractionation (Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Plasma Fractionation (Coagulation factor VIII) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Plasma Fractionation (Coagulation factor VIII) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Plasma Fractionation (Coagulation factor IX) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Plasma Fractionation (Coagulation factor IX) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Plasma Fractionation (Private Sector) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Plasma Fractionation (Private Sector) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Plasma Fractionation (Public Sector) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Plasma Fractionation (Public Sector) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Plasma Fractionation (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Plasma Fractionation (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Plasma Fractionation (Immunology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Plasma Fractionation (Immunology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Plasma Fractionation (Hematology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Plasma Fractionation (Hematology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Plasma Fractionation (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Plasma Fractionation (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Plasma Fractionation (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Plasma Fractionation (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Plasma Fractionation (Clinical Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Plasma Fractionation (Clinical Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Plasma Fractionation (Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Plasma Fractionation (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: North America: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: North America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: United States: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: United States: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Canada: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Canada: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Asia-Pacific: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Asia-Pacific: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: China: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: China: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Japan: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Japan: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: India: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: India: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: South Korea: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: South Korea: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Australia: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Australia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Indonesia: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Indonesia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Europe: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Europe: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Germany: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Germany: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: France: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: France: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: United Kingdom: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: United Kingdom: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Italy: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Italy: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Spain: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Spain: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Russia: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Russia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Latin America: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Latin America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Brazil: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Brazil: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Mexico: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Mexico: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Middle East and Africa: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Middle East and Africa: Plasma Fractionation Market: Breakup by Country (in %), 2023
Figure 83: Middle East and Africa: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Global: Plasma Fractionation Industry: SWOT Analysis
Figure 85: Global: Plasma Fractionation Industry: Value Chain Analysis
Figure 86: Global: Plasma Fractionation Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Plasma Fractionation Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Plasma Fractionation Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Plasma Fractionation Market Forecast: Breakup by Sector (in Million US$), 2024-2032
Table 4: Global: Plasma Fractionation Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Plasma Fractionation Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Plasma Fractionation Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Plasma Fractionation Market: Competitive Structure
Table 8: Global: Plasma Fractionation Market: Key Players

02-2729-4219

+886-2-2729-4219